Bright Futures and Genomic Duties
By Jonathan Kahn, Biopolitical Times guest contributor
| 04. 20. 2011
A recent issue of Nature reviewed the accomplishments of the Human Genome Project 10 years after the grand announcement of the completion of the first draft of the human genome. With a cover declaring "The Future is Bright," the issue featured an article by Eric Green, the new director of National Human Genome Research Institute, and others [pdf] that was intended to "articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine."
Understandably, the authors accentuate the positive and express both hope and enthusiasm for the future of genomic research. To realize the great promise of ongoing genomic research, they also identify several "imperatives for genomic medicine," specifically:
- Making genomics-based diagnostics routine
- Defining the genetic components of disease
- Comprehensive characterization of cancer genomes
- Practical systems for clinical genomic informatics
- The role of the human microbiome in health and disease
These are relatively unexceptional goals and certainly worthy of pursuit. To propel genomic research down this path, however, the authors also declare that "Effective genomics research needs continual, broad...
Related Articles
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...
By Megan Molteni, STAT News | 06.05.2026
In 2021, the federal office charged with ensuring that the vast research enterprise bankrolled by the Department of Health and Human Services keeps study participants safe, received a report of a death by suicide involving a person enrolled in a...
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...